Search Results - "Gandhi, Neel R"

Refine Results
  1. 1

    Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis by Gandhi, Neel R, Dr, Nunn, Paul, FRCP, Dheda, Keertan, PhD, Schaaf, H Simon, Prof, Zignol, Matteo, MD, van Soolingen, Dick, PhD, Jensen, Paul, PhD, Bayona, Jaime, MD

    Published in The Lancet (British edition) (22-05-2010)
    “…Summary Although progress has been made to reduce global incidence of drug-susceptible tuberculosis, the emergence of multidrug-resistant (MDR) and extensively…”
    Get full text
    Journal Article
  2. 2

    Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis by Dheda, Keertan, Prof, Gumbo, Tawanda, MD, Gandhi, Neel R, PhD, Murray, Megan, ScD, Theron, Grant, PhD, Udwadia, Zarir, MD, Migliori, G B, MD, Warren, Robin, PhD

    Published in The lancet respiratory medicine (01-04-2014)
    “…Summary Extensively drug-resistant tuberculosis is a burgeoning global health crisis mainly affecting economically active young adults, and has high mortality…”
    Get full text
    Journal Article
  3. 3

    Tuberculosis Infectiousness and Host Susceptibility by Turner, Richard D., Chiu, Christopher, Churchyard, Gavin J., Esmail, Hanif, Lewinsohn, David M., Gandhi, Neel R., Fennelly, Kevin P.

    Published in The Journal of infectious diseases (03-11-2017)
    “…The transmission of tuberculosis is complex. Necessary factors include a source case with respiratory disease that has developed sufficiently for Mycobacterium…”
    Get full text
    Journal Article
  4. 4

    Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis by Orenstein, Evan W, BS, Basu, Sanjay, PhD, Shah, N Sarita, MD, Andrews, Jason R, MD, Friedland, Gerald H, MD, Moll, Anthony P, MBChB, Gandhi, Neel R, MD, Galvani, Alison P, PhD

    Published in The Lancet infectious diseases (01-03-2009)
    “…Summary Multidrug-resistant (MDR) tuberculosis is a growing clinical and public-health concern. To evaluate existing evidence regarding treatment regimens for…”
    Get full text
    Journal Article
  5. 5

    Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities by Auld, Sara C, Shah, N Sarita, Mathema, Barun, Brown, Tyler S, Ismail, Nazir, Omar, Shaheed Vally, Brust, James C M, Nelson, Kristin N, Allana, Salim, Campbell, Angela, Mlisana, Koleka, Moodley, Pravi, Gandhi, Neel R

    Published in The European respiratory journal (01-10-2018)
    “…Despite evidence that transmission is driving an extensively drug-resistant TB (XDR-TB) epidemic, our understanding of where and between whom transmission…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011-2015 by Haddad, Maryam B, Raz, Kala M, Lash, Timothy L, Hill, Andrew N, Kammerer, J Steve, Winston, Carla A, Castro, Kenneth G, Gandhi, Neel R, Navin, Thomas R

    Published in Emerging infectious diseases (01-10-2018)
    “…We used tuberculosis genotyping results to derive estimates of prevalence of latent tuberculosis infection in the United States. We estimated <1% prevalence in…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa by Niehaus, Abraham J, Mlisana, Koleka, Gandhi, Neel R, Mathema, Barun, Brust, James C M

    Published in PloS one (02-09-2015)
    “…Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are often few remaining active medications and limited diagnostic options…”
    Get full text
    Journal Article
  12. 12

    Exogenous Reinfection as a Cause of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Rural South Africa by Andrews, Jason R., Gandhi, Neel R., Moodley, Prashini, Shah, N. Sarita, Bohlken, Louise, Moll, Anthony P., Pillay, Manormoney, Friedland, Gerald, Sturm, A. Willem

    Published in The Journal of infectious diseases (01-12-2008)
    “…Background. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are now major threats in areas of South Africa with a high…”
    Get full text
    Journal Article
  13. 13

    pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia by Allana, Salim, Shashkina, Elena, Mathema, Barun, Bablishvili, Nino, Tukvadze, Nestani, Shah, N Sarita, Kempker, Russell R, Blumberg, Henry M, Moodley, Pravi, Mlisana, Koleka, Brust, James C M, Gandhi, Neel R

    Published in Emerging infectious diseases (01-03-2017)
    “…Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is not routinely available. We found polymorphisms in the pncA…”
    Get full text
    Journal Article
  14. 14
  15. 15

    CD4 T Cells in Mycobacterium tuberculosis and Schistosoma mansoni Co-infected Individuals Maintain Functional TH1 Responses by McLaughlin, Taryn A, Khayumbi, Jeremiah, Ongalo, Joshua, Tonui, Joan, Campbell, Angela, Allana, Salim, Gurrion Ouma, Samuel, Odhiambo, Felix Hayara, Gandhi, Neel R, Day, Cheryl L

    Published in Frontiers in immunology (07-02-2020)
    “…(Mtb) is a serious public health concern, infecting a quarter of the world and leading to 10 million cases of tuberculosis (TB) disease and 1. 5 million deaths…”
    Get full text
    Journal Article
  16. 16

    Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community by Andrews, Jason R, Shah, N Sarita, Weissman, Darren, Moll, Anthony P, Friedland, Gerald, Gandhi, Neel R

    Published in PloS one (29-12-2010)
    “…Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) have emerged in high-HIV-prevalence settings, which generally lack laboratory…”
    Get full text
    Journal Article
  17. 17

    Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa by Kapwata, Thandi, Morris, Natashia, Campbell, Angela, Mthiyane, Thuli, Mpangase, Primrose, Nelson, Kristin N, Allana, Salim, Brust, James C M, Moodley, Pravi, Mlisana, Koleka, Gandhi, Neel R, Shah, N Sarita

    Published in PloS one (13-10-2017)
    “…KwaZulu-Natal province, South Africa, has among the highest burden of XDR TB worldwide with the majority of cases occurring due to transmission. Poor access to…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa by Magee, Matthew J, Sun, Yan V, Brust, James C M, Shah, N Sarita, Ning, Yuming, Allana, Salim, Campbell, Angela, Hui, Qin, Mlisana, Koleka, Moodley, Pravi, Gandhi, Neel R

    Published in PloS one (01-07-2017)
    “…Vitamin D modulates the inflammatory and immune response to tuberculosis (TB) and also mediates the induction of the antimicrobial peptide cathelicidin…”
    Get full text
    Journal Article
  20. 20